SAVA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cassava Sciences Inc (SAVA) is not a strong buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is weak, with declining net income and EPS. There are no significant positive catalysts, and technical indicators suggest a neutral trend. While hedge funds are buying, insider activity remains neutral, and there is no recent news or congress trading data to support a bullish case. The lack of Intellectia Proprietary Trading Signals further reduces the attractiveness of this stock at the moment.
The MACD is slightly positive but contracting, RSI is neutral at 48.599, and moving averages are converging, indicating no clear trend. The stock is trading near its pivot level of 2.037, with key resistance at 2.17 and support at 1.903.
Hedge funds are significantly increasing their buying activity, with a 3083.17% increase over the last quarter.
The company's financials show a significant decline in net income (-61.32% YoY) and EPS (-62.07% YoY). There is no recent news or congress trading data to provide a positive catalyst. Additionally, the stock has a low probability of significant short-term gains based on candlestick pattern analysis.
In Q3 2025, revenue remained at $0 with no growth. Net income dropped to -$10.81 million (-61.32% YoY), and EPS fell to -0.22 (-62.07% YoY). Gross margin remained at 0%.
No recent analyst rating or price target changes are available for this stock.
